Get started
Author

Gauthier Pellet

Observed names: G Pellet, G. Pellet
ORCID: 0000-0002-8022-1115
Observed ORCID: 0000-0002-8022-1115
OpenAlex ID: A5028428527
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
2018 · Gauthier Pellet, Carmen Stefanescu, et al. · Clinical Gastroenterology and Hepatology · 79
PDF
Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study
2022 · Laurent Peyrin-Biroulet, Guillaume Bouguen, et al. · Digestive Diseases and Sciences · 34
PDF
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis
2022 · Pauline Veyrard, Gauthier Pellet, et al. · Clinical Gastroenterology and Hepatology · 28
PDF
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn’s Disease: A Retrospective Study From 2 Referral Centers
2022 · Pauline Rivière, Caitlyn Kanters, et al. · Inflammatory Bowel Diseases · 22
Dermatite irritative par contact direct avec du laurier rose (Nerium oleander)
2015 · G. Pellet, M. Masson-Regnault, et al. · Annales de Dermatologie et de Vénéréologie · 8
Male gender is associated with informal caregiver burden in patients with chronic intestinal failure treated with home parenteral nutrition
2022 · Jean Castinel, Gauthier Pellet, et al. · Journal of Parenteral and Enteral Nutrition · 6
Intestinal failure–associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study
2025 · Sarah Frezet, Paul Hermabessière, et al. · Journal of Parenteral and Enteral Nutrition · 4
Tu1508: EFFICACY AND SAFETY OF INDUCTION THERAPY WITH CALCINEURIN INHIBITORS IN COMBINATION WITH USTEKINUMAN FOR ACUTE SEVERE COLITIS
2022 · Pauline Veyrard, Gauthier Pellet, et al. · Gastroenterology · 1
Continuous Glucose Monitoring–Guided Insulin Optimization in Patients Receiving Nocturnal Parenteral Nutrition
2026 · Laurianne Kerlogot, Vincent Rigalleau, et al.
Continuous Glucose Monitoring–Guided Insulin Optimization in Patients Receiving Nocturnal Parenteral Nutrition
2026 · Laurianne Kerlogot, Vincent Rigalleau, et al. · Diabetes Care
High parenteral carbohydrate intakes in patients with chronic intestinal failure are associated with accumulation of advanced glycation end products.
2022 · Candice Tetard, Florian Poullenot, et al. · Research Square
PDF
Mo1542: COMPARED EFFICACY OF USTEKINUMAB AND ANTI-TNF AGENTS AS FIRST-LINE BIOLOGICAL THERAPY IN LUMINAL CROHN’S DISEASE: A TWO-CENTER RETROSPECTIVE STUDY.
2022 · Pauline Rivière, Caitlyn Kanters, et al. · Gastroenterology
P393 Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis
2022 · P Veyrard, G Pellet, et al. · Journal of Crohn s and Colitis
PDF
P524 Compared efficacy of ustekinumab and anti-TNF agents as first-line biological therapy in luminal Crohn’s disease
2022 · P Riviere, C Kanters, et al. · Journal of Crohn s and Colitis
PDF
Reply
2018 · David Laharie, Gauthier Pellet · Clinical Gastroenterology and Hepatology
Works count: 15
Citation count: 182
H-index: 6
I10-index: 4
Year
Topic
Type